Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Newly-Identified Exercise Gene May Treat Depression

By Biotechdaily staff writers
Posted on 17 Dec 2007
Boosting an exercise-related gene in the brain works as a powerful anti-depressant in mice--a finding that could lead to a new anti-depressant drug target.

"The VGF exercise-related gene and target for drug development could be even better than chemical antidepressants because it is already present in the brain,” said Dr. More...
Ronald Duman, professor of psychiatry at Yale School of Medicine (New Haven, CT, USA) and senior author of the study, which was published in the online edition of the journal Nature Medicine on December 2, 2007.

Depression affects 16% of the population in the United States, at a related cost of US$83 billion each year. Currently available anti-depressants help 65% of patients and require weeks to months before the patients experience relief. According to Dr. Duman, it is known that exercise improves brain function and mental health, and provides protective benefits in the event of a brain injury or disease, but how this all occurs in the brain is not well understood. He reported that existing medications take so long to work indicates that some neuronal adaptation or plasticity is needed. He and his colleagues designed a custom microarray that was optimized to show small alteration in gene expression, particularly in the brain's hippocampus, a limbic structure highly sensitive to stress hormones, depression, and anti-depressants.

The researchers then compared the brain activity of sedentary mice to those who were given running wheels. The researchers observed that the mice with wheels within one week were running more than six miles each night. Four independent array analyses of the mice turned up 33 hippocampal exercise-regulated genes--27 of which had never been identified before. The action of one gene in particular--VGF--was greatly enhanced by exercise. Moreover, administering VGF functioned like a powerful anti-depressant, while suppressing VGF inhibited the effects of exercise and induced depressive-like behavior in the mice.

"Identification of VGF provides a mechanism by which exercise produces antidepressant effects,” Dr. Duman said. "This information further supports the benefits of exercise and provides a novel target for the development of new antidepressants with a completely different mechanism of action than existing medications.”


Related Links:
Yale University School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.